Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $18.05 up 2.32% from its previous closing price of $17.64. In other words, the price has increased by $2.32 from its previous closing price. On the day, 1.28 million shares were traded. CNTA stock price reached its highest trading level at $18.11 during the session, while it also had its lowest trading level at $17.23.
Ratios:
For a deeper understanding of Centessa Pharmaceuticals plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.12 and its Current Ratio is at 10.12. In the meantime, Its Debt-to-Equity ratio is 0.34 whereas as Long-Term Debt/Eq ratio is at 0.34.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on July 21, 2025, initiated with a Buy rating and assigned the stock a target price of $30.
On May 28, 2025, Needham started tracking the stock assigning a Buy rating and target price of $35.
On May 08, 2025, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $30.Chardan Capital Markets initiated its Buy rating on May 08, 2025, with a $30 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 15 ’25 when HUSSAIN IQBAL J sold 6,000 shares for $17.23 per share. The transaction valued at 103,380 led to the insider holds 105,386 shares of the business.
HUSSAIN IQBAL J bought 6,000 shares of CNTA for $103,380 on Aug 15 ’25. On Jul 29 ’25, another insider, Accardi Mario Alberto, who serves as the President, Orexin Program of the company, sold 8,322 shares for $15.23 each. As a result, the insider received 126,751 and left with 208,163 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 2420017664 and an Enterprise Value of 2287442432. For the stock, the TTM Price-to-Sale (P/S) ratio is 160.50 while its Price-to-Book (P/B) ratio in mrq is 7.01. Its current Enterprise Value per Revenue stands at 152.496 whereas that against EBITDA is -11.098.
Stock Price History:
The Beta on a monthly basis for CNTA is 1.49, which has changed by 0.4662876 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $9.60. The 50-Day Moving Average of the stock is 22.84%, while the 200-Day Moving Average is calculated to be 18.56%.
Shares Statistics:
For the past three months, CNTA has traded an average of 1.10M shares per day and 1149980 over the past ten days. A total of 133.91M shares are outstanding, with a floating share count of 85.14M. Insiders hold about 36.01% of the company’s shares, while institutions hold 56.11% stake in the company. Shares short for CNTA as of 1753920000 were 4362489 with a Short Ratio of 3.98, compared to 1751241600 on 3836998. Therefore, it implies a Short% of Shares Outstanding of 4362489 and a Short% of Float of 3.85.
